Fanen Biotechnology Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 6

Fanen Biotechnology General Information

Description

Manufacturer of tumor immunotherapy drugs aims to improve survival and quality of life for cancer patients. The company's offerings feature personalized CAR-T, TCR-T cell therapies, tumor vaccines, and immune checkpoint inhibitors, combined with proprietary diagnostics and GMP-grade production capabilities, which help hospitals and cancer treatment centers access tailored and effective immunotherapies, enabling the precise and efficient treatment of solid tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6th Floor, Building G, Number 188 Kaiyuan Avenue
  • Guangzhou High-tech Industrial Development Zone
  • Guangzhou, Guangdong 510535
  • China
+86 020
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 6th Floor, Building G, Number 188 Kaiyuan Avenue
  • Guangzhou High-tech Industrial Development Zone
  • Guangzhou, Guangdong 510535
  • China
+86 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fanen Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 17-Apr-2025 Completed Generating Revenue
1. Later Stage VC 03-Aug-2022 Completed Generating Revenue
To view Fanen Biotechnology’s complete valuation and funding history, request access »

Fanen Biotechnology Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Zhongshan Health Base Group Government Minority
Zhongshan Torch Electronic Industry Fund Management Venture Capital Minority
Beijing Huafang Investment Co. Venture Capital Minority
Holley Group Corporation Minority
Panacea Capital (California) Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Fanen Biotechnology FAQs

  • When was Fanen Biotechnology founded?

    Fanen Biotechnology was founded in 2016.

  • Where is Fanen Biotechnology headquartered?

    Fanen Biotechnology is headquartered in Guangzhou, China.

  • What industry is Fanen Biotechnology in?

    Fanen Biotechnology’s primary industry is Drug Discovery.

  • Is Fanen Biotechnology a private or public company?

    Fanen Biotechnology is a Private company.

  • What is Fanen Biotechnology’s current revenue?

    The current revenue for Fanen Biotechnology is .

  • How much funding has Fanen Biotechnology raised over time?

    Fanen Biotechnology has raised $14.8M.

  • Who are Fanen Biotechnology’s investors?

    Zhongshan Health Base Group, Zhongshan Torch Electronic Industry Fund Management, Beijing Huafang Investment Co., Holley Group, and Panacea Capital (California) are 5 of 6 investors who have invested in Fanen Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process